Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Conditions

Colorectal Neoplasms 218 Rectal Neoplasms 107 Colonic Neoplasms 91 Pancreatic Neoplasms 88 Stomach Neoplasms 75 Neoplasm Metastasis 61 Esophageal Neoplasms 40 Carcinoma, Hepatocellular 31 Lymphoma 24 Adenocarcinoma Of Esophagus 24 Neoplasms 23 Precursor Cell Lymphoblastic Leukemia-Lymphoma 22 Adenocarcinoma 19 Leukemia 17 Cholangiocarcinoma 15 Biliary Tract Neoplasms 15 Burkitt Lymphoma 14 Gastrointestinal Neoplasms 12 Lymphoma, Non-Hodgkin 11 Osteosarcoma 9 Liver Neoplasms 9 Gallbladder Neoplasms 9 Esophageal Squamous Cell Carcinoma 9 Peritoneal Neoplasms 8 Leukemia, Myeloid, Acute 8 Myelodysplastic Syndromes 7 Lymphoma, Large B-Cell, Diffuse 7 Bile Duct Neoplasms 7 Unspecified Adult Solid Tumor, Protocol Specific 6 Multiple Myeloma 6

Interventions

folfirinox 1 Oxaliplatin 1 Leucovorin 1 Irinotecan 1 Fluorouracil 1 Capecitabine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Ampullary Adenocarcinoma × Leucovorin × Clear all

NCT06068023 2023-10-05

ADAPTA

Fondazione Poliambulanza Istituto Ospedaliero

Ampullary Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡